CSTL
Castle Biosciences, Inc. Common StockstockNASDAQ
Market OpenNov 19, 2026 9:40:45 AM EST
33.74USD+1.078%(+0.36)36,153
CSTL Financials
In Q3 FY 2026 (ended ), Castle Biosciences, Inc. Common Stock (CSTL) reported revenue of $102.89M, net income of −$4.1M, operating cash flow of $19.74M, and assets of $579.41M (filed ).
Loading financial statements…